And you think that once the T315i arm of the trial ends (enrollment that is)(second half 2011 according to The Harv), they're just going to give the results?
By chance, did you happen to read anything about a six-month follow-up, or did you glaze over that one?
So, what's going to happen when the T315i cohort ends enrollment in 2011? LOL, do you think that they are going to just shove 100 patients in the trial in the next month and have data for you in six-months????
I agree with your prediction. Whether it is 1 or all 3 of the T315I cohorts stopped early, I believe in mid 2010, it will be huge. We'll see T315I revenue of some sort in 2011, ex-partnership rev.